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strated that mature B cells can transform into cells with the morphology and the immunophenotype of H-RS cells. 6 In view of these findings, the above two subtypes of H-RS may represent the same entity. It is possible that H-RS in CLL may result from genetic alterations that result in the morphologic and immunophenotypic features, cytokine production profile and stromal reactions that manifest as HD. 6 An association with Epstein-Barr virus infection has been described in these cases. 7 This was not tested in our patients. Two of our patients died at 4 months and 6 months after the diagnosis of H-RS but the third patient is alive 48 months after the development of H-RS. The median survival of such patients in the previous series has been reported to be 13 months. [1] [2] [3] We conclude that in addition to the well recognised large cell transformation, development of rarer type of H-RS needs to be considered in CLL patients with progressive disease. The authors fail to discuss their findings in relation to the results of the available comprehensive studies on the subject. [2] [3] [4] The study of Wagner et al, 5 cited by the authors, was the first analysis of V genes in MM; however, it was confounded by the inclusion of only seven MM cases among a large group of other B cell lymphoproliferative disorders, three of which were carrying out-of-frame V genes presumably derived from -expressing MM (since PCR was applied on genomic DNA); therefore, V /J gene usage, hypermutation and N-region diversity could not be reliably discerned as a result of the small number of -expressing MM. 5 We and others [2] [3] [4] first demonstrated that the expressed clonogenic V and V genes in MM, similar to V H genes, are usually hypermutated indicating the presumed nature of their precursor, ontogenetically assigned to post-germinal center (GC) memory B cell, that has undergone antigen selection.
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N-nucleotide insertions in V -J junctions, reflecting the activity of TdT at the time of -light chain (LC) gene assembly as found by Kiyoi et al, 1 is a well recognized phenomenon in B cell lymphoproliferative disorders. [2] [3] [4] [5] However, N-nucleotide insertions in V -J junctions has never been observed in our studies in MM, 4 while functional V -J rearrangements have not been found to carry N-nucleotide insertions at the junction or deletions in the J gene segment in normal human B cells 4 and very rarely (3/160 sequenced V -J junctions) in the mouse B cell repertoire, indicating loss of TdT activity before -LC rearrangement takes place. One can hypothesize that slippage replication might account for the addition of some nucleotides at the 3Ј-end of V or 5Ј-end of J genes. Alternatively, reactivation of the recombinase machinery (RAG1 and RAG2 genes) together with TdT in germinal center (GC) B cells, undergoing receptor editing, might account for this phenomenon, 6 but the data presented by the authors 1 cannot support this explanation.
The cohort of patients analyzed by Kiyoi et al 1 does not appear to be representative of what happens in most series since the authors included four cases (out of 31; 12%) of IgD myeloma, an incidence much higher than the usual 1-2% occurrence of this subclass in most clinical series. IgD myelomas represent a subgroup with a very high load of mutations within V H genes (up to 80) with almost all expressing -LCs; corresponding to IgM −
/IgD
+ GC B cells that have undergone a peculiar C-to-C␦ switch recombination. 7 In the study of Kiyoi et al, 1 3/4 IgD MM were of the -subtype and one of these carried an unusually high load of mutations within the V region.
The total burden of mutations in the study of Kiyoi et al 1 ranges from 2.7 to 34.1%, and in some sequences appears unacceptably high compared to previous experiences 2,3 for presumed functional V L genes. In addition, mutations in the J regions can be observed as reported by Kiyoi et al; 1 however, their frequency appears very high in many cases comparable to that of the respective V genes. It is well recognized that the intronic enhancer of Ig (Ein) located between J and C regions in V H and V genes (missing in V ), acts as a sort of boundary for somatic hypermutation and relatively, but does not absolutely, prevent the occurrence of mutations downstream. However, in V genes, where the Ein is lacking, the mutation tract is extended into the C exon, although at a 100-fold less frequency of mutations in the latter region. Despite providing data regarding the percentage of replacement (R) and silent (S) mutations as well as the R/S ratios in CDRs and FWRs, the authors have not carried out the acceptable statistical analysis pertaining to the significance of their distribution that might imply antigen selection (binomial probability distribution taking into account the modifications proposed by Chang and Casali). 8 Without such an analysis it is not possible to discern to what percentage the V L genes in MM have contributed to the antigen selection process imposed on MM B cell progenitors (27% in the study of Sahota et al 3 and 55% in the study of Kosmas et al 4 ). However, despite high levels of R mutations and R/S ratios in CDRs, in many cases their clustering in CDRs is not at levels of significance. [2] [3] [4] It is possible that the application of strict mathematical rules and calculations would lead to an underestimate or a minimum estimate of the importance of antigen selection. Moreover, critical amino acid substitutions within the CDRs, even at low levels, may confer high affinity for antigen and therefore provide the particular B cell clone with the appropriate advantage for survival after antigen binding, whereas a tendency of more S and less R mutations in FWRs might constitute a surrogate measure of selection.
It is believed, that should the authors of that study 1 provide answers to the above raised issues, their report will likewise constitute an important contribution to the large body of data accumulated over the last 2 years concerning V L gene usage, junctional diversity and hypermutation in MM.
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